Aug 06, 2024 / 08:30AM GMT
Dirk Neumüller Biotest AG-Public Relations
Hello, ladies and gentlemen. I'm sorry for the delay. We faced some technical problems. We apologize for this, and so welcome to our today's conference call. For the half year figures of 2024. With me are Peter Janssen, the CEO of Biotest; and Ainhoa Mendizabal, the CFO of Biotest.
And for your information, the presentation and the call will be recorded and it will be available after the call for you at your website under Investor Relations news and publication and presentation. -- Okay, then I would like to hand over to Peter for the presentation.
Peter Janssen - Biotest AG - Chief Operations Officer, Member of the Management Board
Thank you, Dirk, and good morning, everyone, and thanks for your patience. Welcome to our today's earnings call. We issued the summary last week, but planned the full report and our earnings call this earnings call today such that we could also include our financing situation.
In fact, we have repaid the loan we had with Alcentra -- bank we gave, which came to
Q2 2024 Biotest AG Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot